NTLA : Intellia Therapeutics stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2025-07-09 |
|---|---|---|---|---|
| 2025 | $11.97 | $11.52 | $12.25 | -1.34% |
| 2026 | $11.58 | $11.04 | $13.28 | -4.52% |
| 2027 | $14.73 | $13.93 | $15.39 | 21.41% |
| 2028 | $13.37 | $13.09 | $14.11 | 10.22% |
| 2029 | $18.62 | $14.75 | $21.85 | 53.53% |
| 2030 | $23.21 | $22.25 | $23.92 | 91.35% |
| 2031 | $24.31 | $24.0 | $24.54 | 100.39% |
| 2032 | $25.19 | $24.52 | $25.67 | 107.67% |
| 2033 | $25.44 | $24.69 | $25.69 | 109.71% |
| 2034 | $22.71 | $20.05 | $24.42 | 87.25% |
| 2035 | $17.04 | $15.1 | $19.2 | 40.46% |
The 21 Wall Street analysts offering Intellia Therapeutics stock forecast in the last 6 months have average price target of
$34.38 with a high forecast of $68.0 and a low forecast of $10.0.
The average Intellia Therapeutics stock forecast represents a 183.43%
increase from the last price of $12.1300001144409.
For Intellia Therapeutics stock forecast for 2025, 5 predictions are offered for each month of 2025 with average Intellia Therapeutics stock
forecast of $11.97, a high forecast of $12.25, and a low forecast of $11.52.
The average Intellia Therapeutics stock forecast 2025 represents a -1.34%
decrease from the last price of $12.1300001144409.
For Intellia Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Intellia Therapeutics stock
forecast of $11.58, a high forecast of $13.28, and a low forecast of $11.04.
The average Intellia Therapeutics stock forecast 2026 represents a -4.52%
decrease from the last price of $12.1300001144409.
For Intellia Therapeutics stock forecast for 2028, 12 predictions are offered for each month of 2028 with average Intellia Therapeutics stock
forecast of $13.37, a high forecast of $14.11, and a low forecast of $13.09.
The average Intellia Therapeutics stock forecast 2028 represents a 10.22%
increase from the last price of $12.1300001144409.
For Intellia Therapeutics stock forecast for 2030 (5 year), 12 predictions are offered for each month of 2030 with average Intellia Therapeutics stock
forecast of $23.21, a high forecast of $23.92, and a low forecast of $22.25.
The average Intellia Therapeutics stock forecast 2030 represents a 91.35%
increase from the last price of $12.1300001144409.
For Intellia Therapeutics stock forecast 2031, 12 predictions are offered for each month of 2031 with average Intellia Therapeutics stock
forecast of $24.31, a high forecast of $24.54, and a low forecast of $24.0.
The average Intellia Therapeutics stock forecast 2031 represents a 100.39%
increase from the last price of $12.1300001144409.
For Intellia Therapeutics stock forecast for 2035 (10 year), 7 predictions are offered for each month of 2035 with average Intellia Therapeutics stock
forecast of $17.04, a high forecast of $19.2, and a low forecast of $15.1.
The average Intellia Therapeutics stock forecast 2035 represents a 40.46%
increase from the last price of $12.1300001144409.
Please, see more forecasts below.
NTLA : Intellia Therapeutics stock forecast by Wall Street Analysts
The average Intellia Therapeutics stock forecast from last 6 month is $34.38, and this show a -28.53% decrease in average from the prior price target of the each prediction. Also, this average forecast of $34.38 represents a -34.97% decrease from the past average forecast of $52.87, 6 months ago from 15 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2025-06-16 | HC Wainwright & Co. | $30.0000 | $30.0000 | Buy |
| 2025-06-03 | Canaccord Genuity | $74.0000 | $54.0000 | Buy |
| 2025-05-29 | HC Wainwright & Co. | $30.0000 | $30 | Buy |
| 2025-05-20 | HC Wainwright & Co. | $30.0000 | $30 | Buy |
| 2025-05-19 | Wedbush | $10.0000 | $10.0000 | Neutral |
| 2025-05-12 | Guggenheim | $55.0000 | $45.0000 | Buy |
| 2025-05-09 | Chardan Capital | $68.00 | $68.00 | Buy |
| 2025-05-09 | Citigroup | $14.00 | $10.0000 | Neutral |
| 2025-04-21 | Wolfe Research | $21.0000 | Outperform | |
| 2025-03-05 | HC Wainwright & Co. | $30 | Buy | |
| 2025-03-04 | Truist Securities | $90.0000 | $50 | Buy |
| 2025-02-28 | JP Morgan | $45.0000 | $13.0000 | Neutral |
| 2025-02-28 | Chardan Capital | $91.00 | $68.0000 | Buy |
| 2025-02-28 | Wells Fargo | $60.00 | $50.0000 | Overweight |
| 2025-02-28 | Citigroup | $12.0000 | $14.0000 | Neutral |
| 2025-02-28 | Barclays | $55.00 | $26.0000 | Overweight |
| 2025-01-27 | Morgan Stanley | $56.0000 | $11.0000 | Equal-Weight |
| 2025-01-14 | Goldman Sachs | $19.0000 | $12 | Neutral |
| 2025-01-13 | Oppenheimer | $60.00 | $40 | Outperform |
| 2025-01-10 | BMO Capital | $70.00 | $50 | Outperform |
| 2025-01-10 | Wells Fargo | $70.00 | $60.0000 | Overweight |
| 2024-11-19 | Canaccord Genuity | $90.0000 | $90.0000 | Buy |
| 2024-11-18 | Chardan Capital | $88.0000 | $91.0000 | Buy |
| 2024-11-18 | Wedbush | $14.0000 | $14 | Neutral |
| 2024-11-18 | Wells Fargo | $80.0000 | $70.0000 | Overweight |
| 2024-11-11 | Oppenheimer | $70.00 | $60 | Outperform |
| 2024-11-08 | Barclays | $76.0000 | $55.0000 | Overweight |
| 2024-10-25 | Baird | $24.0000 | $18 | Neutral |
| 2024-10-25 | Goldman Sachs | $31.0000 | $20 | Neutral |
| 2024-10-25 | Citigroup | $25.0000 | $19.0000 | Neutral |
| 2024-10-24 | Chardan Capital | $94.0000 | $88 | Buy |
| 2024-09-19 | RBC Capital | $54.00 | $54.00 | Outperform |
| 2024-09-17 | Jones Trading | $41.0000 | Buy | |
| 2024-09-11 | Stifel | $80.0000 | $64 | Buy |
| 2024-08-12 | JP Morgan | $61.0000 | $55.0000 | Overweight |
| 2024-08-09 | RBC Capital | $60.0000 | $54 | Outperform |
Intellia Therapeutics stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2025-07-11 | $11.36 | -6.36% |
| 2025-07-14 | $11.45 | 0.81% |
| 2025-07-15 | $11.81 | 3.12% |
| 2025-07-16 | $12.23 | 3.55% |
| 2025-07-17 | $12.11 | -0.92% |
NTLA : Long term Intellia Therapeutics stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2025 Aug. is $12.25 , for 2026 Jul. is $11.22 , for 2029 Jul. is $19.08 , for 2030 Jul. is $23.28 , for 2034 Jul. is $22.86 , and for 2035 Jul. is $15.10.
NTLA : Intellia Therapeutics stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Aug. | $12.25 | 0.97% |
| 2025 Sep. | $12.19 | -0.48% |
| 2025 Oct. | $12.07 | -1.00% |
| 2025 Nov. | $11.81 | -2.14% |
| 2025 Dec. | $11.52 | -2.44% |
NTLA : Intellia Therapeutics stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $11.32 | -1.78% |
| 2026 Feb. | $11.16 | -1.36% |
| 2026 Mar. | $11.09 | -0.65% |
| 2026 Apr. | $11.05 | -0.33% |
| 2026 May. | $11.04 | -0.11% |
| 2026 Jun. | $11.10 | 0.50% |
| 2026 Jul. | $11.22 | 1.08% |
| 2026 Aug. | $11.38 | 1.47% |
| 2026 Sep. | $11.65 | 2.36% |
| 2026 Oct. | $12.07 | 3.59% |
| 2026 Nov. | $12.63 | 4.65% |
| 2026 Dec. | $13.28 | 5.19% |
NTLA : Intellia Therapeutics stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $13.94 | 4.96% |
| 2027 Feb. | $14.54 | 4.31% |
| 2027 Mar. | $15.06 | 3.54% |
| 2027 Apr. | $15.35 | 1.97% |
| 2027 May. | $15.39 | 0.20% |
| 2027 Jun. | $15.27 | -0.77% |
| 2027 Jul. | $15.09 | -1.17% |
| 2027 Aug. | $14.90 | -1.27% |
| 2027 Sep. | $14.67 | -1.55% |
| 2027 Oct. | $14.43 | -1.63% |
| 2027 Nov. | $14.17 | -1.79% |
| 2027 Dec. | $13.93 | -1.71% |
NTLA : Intellia Therapeutics stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $13.70 | -1.60% |
| 2028 Feb. | $13.49 | -1.56% |
| 2028 Mar. | $13.31 | -1.32% |
| 2028 Apr. | $13.20 | -0.83% |
| 2028 May. | $13.13 | -0.50% |
| 2028 Jun. | $13.10 | -0.26% |
| 2028 Jul. | $13.09 | -0.10% |
| 2028 Aug. | $13.11 | 0.16% |
| 2028 Sep. | $13.18 | 0.59% |
| 2028 Oct. | $13.36 | 1.32% |
| 2028 Nov. | $13.65 | 2.21% |
| 2028 Dec. | $14.11 | 3.34% |
NTLA : Intellia Therapeutics stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $14.75 | 4.54% |
| 2029 Feb. | $15.56 | 5.52% |
| 2029 Mar. | $16.46 | 5.77% |
| 2029 Apr. | $17.30 | 5.07% |
| 2029 May. | $17.99 | 4.00% |
| 2029 Jun. | $18.56 | 3.17% |
| 2029 Jul. | $19.08 | 2.80% |
| 2029 Aug. | $19.61 | 2.80% |
| 2029 Sep. | $20.18 | 2.92% |
| 2029 Oct. | $20.78 | 2.94% |
| 2029 Nov. | $21.35 | 2.74% |
| 2029 Dec. | $21.85 | 2.34% |
NTLA : Intellia Therapeutics stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $22.25 | 1.83% |
| 2030 Feb. | $22.55 | 1.36% |
| 2030 Mar. | $22.77 | 0.99% |
| 2030 Apr. | $22.94 | 0.71% |
| 2030 May. | $23.05 | 0.51% |
| 2030 Jun. | $23.16 | 0.45% |
| 2030 Jul. | $23.28 | 0.53% |
| 2030 Aug. | $23.43 | 0.65% |
| 2030 Sep. | $23.59 | 0.68% |
| 2030 Oct. | $23.73 | 0.59% |
| 2030 Nov. | $23.84 | 0.45% |
| 2030 Dec. | $23.92 | 0.36% |
NTLA : Intellia Therapeutics stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $24.00 | 0.31% |
| 2031 Feb. | $24.07 | 0.29% |
| 2031 Mar. | $24.13 | 0.26% |
| 2031 Apr. | $24.19 | 0.23% |
| 2031 May. | $24.24 | 0.21% |
| 2031 Jun. | $24.29 | 0.21% |
| 2031 Jul. | $24.35 | 0.23% |
| 2031 Aug. | $24.40 | 0.23% |
| 2031 Sep. | $24.46 | 0.22% |
| 2031 Oct. | $24.50 | 0.17% |
| 2031 Nov. | $24.53 | 0.11% |
| 2031 Dec. | $24.54 | 0.04% |
NTLA : Intellia Therapeutics stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $24.53 | -0.02% |
| 2032 Feb. | $24.52 | -0.05% |
| 2032 Mar. | $24.61 | 0.37% |
| 2032 Apr. | $24.88 | 1.09% |
| 2032 May. | $25.11 | 0.93% |
| 2032 Jun. | $25.32 | 0.84% |
| 2032 Jul. | $25.45 | 0.50% |
| 2032 Aug. | $25.47 | 0.07% |
| 2032 Sep. | $25.49 | 0.12% |
| 2032 Oct. | $25.59 | 0.36% |
| 2032 Nov. | $25.65 | 0.23% |
| 2032 Dec. | $25.67 | 0.08% |
NTLA : Intellia Therapeutics stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $25.68 | 0.04% |
| 2033 Feb. | $25.68 | 0.02% |
| 2033 Mar. | $25.69 | 0.02% |
| 2033 Apr. | $25.69 | 0.00% |
| 2033 May. | $25.68 | -0.05% |
| 2033 Jun. | $25.64 | -0.13% |
| 2033 Jul. | $25.58 | -0.24% |
| 2033 Aug. | $25.48 | -0.38% |
| 2033 Sep. | $25.35 | -0.53% |
| 2033 Oct. | $25.16 | -0.71% |
| 2033 Nov. | $24.94 | -0.89% |
| 2033 Dec. | $24.69 | -1.02% |
NTLA : Intellia Therapeutics stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $24.42 | -1.06% |
| 2034 Feb. | $24.17 | -1.04% |
| 2034 Mar. | $23.93 | -0.99% |
| 2034 Apr. | $23.70 | -0.98% |
| 2034 May. | $23.45 | -1.03% |
| 2034 Jun. | $23.18 | -1.16% |
| 2034 Jul. | $22.86 | -1.38% |
| 2034 Aug. | $22.48 | -1.66% |
| 2034 Sep. | $22.02 | -2.03% |
| 2034 Oct. | $21.48 | -2.49% |
| 2034 Nov. | $20.82 | -3.06% |
| 2034 Dec. | $20.05 | -3.70% |
NTLA : Intellia Therapeutics stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $19.20 | -4.25% |
| 2035 Feb. | $18.34 | -4.44% |
| 2035 Mar. | $17.58 | -4.18% |
| 2035 Apr. | $16.93 | -3.69% |
| 2035 May. | $16.35 | -3.42% |
| 2035 Jun. | $15.76 | -3.62% |
| 2035 Jul. | $15.10 | -4.21% |
Financial Data for Intellia Therapeutics stock
Frequently Asked Questions about Intellia Therapeutics stock forecast
Is Intellia Therapeutics a good long term stock?
From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2025 Aug. is $12.2476835574744 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock cannot be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2026 Jul. is $11.2154293653865 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2029 Jul. is $19.0788725512245 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2030 Jul. is $23.2807662531988 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2034 Jul. is $22.8601712008388 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2035 Jul. is $15.0968477269522
Is Intellia Therapeutics stock overvalued?
Intellia Therapeutics (NTLA) stock is expected to go DOWN . Therefore, AIPickup would say that Intellia Therapeutics (NTLA) stock is overvalued.
Will Intellia Therapeutics stock price go up?
No. The Intellia Therapeutics stock price forecast for 2026 Jul. is $11.2154293653865
Is Intellia Therapeutics stock a good buy now?
Since closing price on 2025-07-09 is $12.1300001144409 and forecast for 2026 Jul. is $11.22, Intellia Therapeutics stock is not a good 1 year investment.
14 Days Historical Data for Intellia Therapeutics stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| NTLA stock price for 2025-06-18 | $9.60 | $9.61 | $9.01 | $9.71 |
| NTLA stock price for 2025-06-20 | $9.20 | $9.74 | $8.95 | $9.94 |
| NTLA stock price for 2025-06-23 | $9.23 | $9.03 | $8.88 | $9.51 |
| NTLA stock price for 2025-06-24 | $9.57 | $9.45 | $9.28 | $9.92 |
| NTLA stock price for 2025-06-25 | $9.56 | $9.57 | $9.30 | $9.66 |
| NTLA stock price for 2025-06-26 | $9.61 | $9.57 | $9.45 | $9.74 |
| NTLA stock price for 2025-06-27 | $9.56 | $9.70 | $9.51 | $10.14 |
| NTLA stock price for 2025-06-30 | $9.38 | $9.56 | $9.33 | $9.68 |
| NTLA stock price for 2025-07-01 | $9.88 | $9.23 | $8.98 | $10.12 |
| NTLA stock price for 2025-07-02 | $10.73 | $9.95 | $9.89 | $11.08 |
| NTLA stock price for 2025-07-03 | $10.74 | $10.80 | $10.45 | $10.90 |
| NTLA stock price for 2025-07-07 | $10.25 | $10.65 | $10.19 | $10.82 |
| NTLA stock price for 2025-07-08 | $11.12 | $10.33 | $10.32 | $11.47 |
| NTLA stock price for 2025-07-09 | $12.13 | $11.50 | $11.40 | $12.24 |